Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Spain Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20103
20114
20134
20142
20164
20174
20183
20195
20203
20214
20225
20232
20248
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting12
Active, not recruiting9
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Novartis Pharmaceuticals5
Eli Lilly and Company4
AstraZeneca3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Seagen Inc.3
Boehringer Ingelheim2
EMD Serono Research & Development Institute, Inc.2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms58
Carcinoma, Non-Small-Cell Lung29
Triple Negative Breast Neoplasms20
Endometrial Neoplasms17
Stomach Neoplasms14
Breast Neoplasms13
Uterine Cervical Neoplasms13
Neoplasms12
Squamous Cell Carcinoma of Head and Neck12
Neoplasm Metastasis11

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.